ProfileGDS4718 / 207266_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 69% 94% 64% 69% 86% 70% 63% 74% 69% 63% 71% 66% 64% 60% 71% 65% 66% 55% 67% 67% 70% 66% 69% 68% 65% 73% 83% 67% 67% 62% 76% 69% 61% 81% 71% 65% 81% 70% 95% 71% 76% 85% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.6074367
GSM549102patient 115, normal, homogenized [OPG study]6.7319369
GSM549104patient 119, normal, homogenized [OPG study]9.9934794
GSM549108patient 138, normal, homogenized [OPG study]6.3816864
GSM549119patient 077, normal, homogenized [OPG study]6.7531169
GSM549133patient 032, cancer, homogenized [OPG study]8.6986786
GSM549139patient 042, cancer, homogenized [OPG study]6.898570
GSM549099patient 107, normal, homogenized [OPG study]6.3329663
GSM549109patient 139, normal, homogenized [OPG study]7.1597774
GSM549110patient 046, normal, homogenized [OPG study]6.726469
GSM549114patient 063, normal, homogenized [OPG study]6.2640563
GSM549122patient 082, normal, homogenized [OPG study]6.984871
GSM549134patient 033, cancer, homogenized [OPG study]6.5557166
GSM549136patient 036, cancer, homogenized [OPG study]6.4213664
GSM549140patient 044, cancer, homogenized [OPG study]6.1272460
GSM549111patient 047, normal, homogenized [OPG study]6.9776471
GSM549113patient 057, normal, homogenized [OPG study]6.4906565
GSM549132patient 031, cancer, homogenized [OPG study]6.5361466
GSM549137patient 038, cancer, homogenized [OPG study]5.8230855
GSM549142patient 047, cancer, homogenized [OPG study]6.6529167
GSM549100patient 110, normal, homogenized [OPG study]6.624367
GSM549107patient 135, normal, homogenized [OPG study]6.8780370
GSM549115patient 068, normal, homogenized [OPG study]6.5920266
GSM549116patient 072, normal, homogenized [OPG study]6.8280969
GSM549120patient 078, normal, homogenized [OPG study]6.6847868
GSM549131patient 030, cancer, homogenized [OPG study]6.4515765
GSM549118patient 074, normal, homogenized [OPG study]7.1393273
GSM549129patient 027, cancer, homogenized [OPG study]8.2460383
GSM549123patient 088, normal, homogenized [OPG study]6.6162367
GSM549124patient 006, cancer, homogenized [OPG study]6.6181267
GSM549126patient 015, cancer, homogenized [OPG study]6.2288162
GSM549128patient 025, cancer, homogenized [OPG study]7.5299676
GSM549103patient 117, normal, homogenized [OPG study]6.7136269
GSM549117patient 073, normal, homogenized [OPG study]6.1121161
GSM549138patient 041, cancer, homogenized [OPG study]8.047181
GSM549141patient 045, cancer, homogenized [OPG study]7.0066971
GSM549130patient 028, cancer, homogenized [OPG study]6.5007265
GSM549101patient 111, normal, homogenized [OPG study]7.9617681
GSM549105patient 128, normal, homogenized [OPG study]6.8770870
GSM549106patient 134, normal, homogenized [OPG study]10.383595
GSM549112patient 048, normal, homogenized [OPG study]6.9541871
GSM549125patient 011, cancer, homogenized [OPG study]7.3884376
GSM549127patient 024, cancer, homogenized [OPG study]8.4338385
GSM549135patient 035, cancer, homogenized [OPG study]8.6738386